Showing results (21-30 of 179) with videos related to

Sort By:
Pageof 18
Molecular Cancer|March 5, 2014
MEK targeting in N-RAS mutated metastatic melanomaJaykumar Thumar, David Shahbazian, Saadia A Aziz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancerMalini Harigopal, Aaron J Berger, Robert L Camp, et al.
Oncoimmunology|January 18, 2021
Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapySandra Martinez-Morilla, Jon Zugazagoitia, Pok Fai Wong, et al.
Journal of Neurosurgery|November 7, 2015
Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?Rovel J Colaco, Pierre Martin, Harriet M Kluger, et al.
Cancer|June 16, 2004
alphaB-crystallin as a marker of lymph node involvement in breast carcinomaDina Chelouche-Lev, Harriet M Kluger, Aaron J Berger, et al.
Oncotarget|June 28, 2014
NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinomaEva Giesen, Lucia B Jilaveanu, Fabio Parisi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancerYasmine Nadler, Robert L Camp, Candice Schwartz, et al.
Molecular Oncology|March 25, 2025
MIF as an oncogenic driver of low-heterogeneity melanomasThuy T Tran, Gabriela Athziri Sánchez-Zuno, Rajan P Kulkarni, et al.
Journal of Translational Medicine|January 16, 2013
Vascularity of primary and metastatic renal cell carcinoma specimensSaadia A Aziz, Joshua Sznol, Adebowale Adeniran, et al.
Pageof 18